ORGANON AND SCHERING CORPORATION TO STOP MALE CONTRACEPTIVE STUDY

Schering AG, Germany and Organon announced that they will continue research in male fertility control separately. Their research collaboration will therefore conclude at the end of the Phase II clinical trial.

BioSpace (http://www.biospace.com/news_story.aspx?StoryID=30369&full=1)